Timing of dosing of zoledronic acid 5mg after recent hip fracture affects antifracture efficacy and reduction of mortality: HORIZON-Recurrent fracture trial Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Colon-Emeric, CS
  • Eriksen, EF
  • Lyles, KW
  • Pieper, CF
  • Magaziner, JS
  • Adachi, Jonathan Derrick
  • Hyldstrup, L
  • Recknor, C
  • Nordsletten, L
  • Lavecchia, C
  • Hu, H
  • Boonen, S
  • Mesenbrink, P

publication date

  • April 1, 2008